When it comes to future developments in lab automation technology, the integration of artificial intelligence (AI) is the top area of anticipation for drug discovery labs.  

This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery Lab Automation: Forecast Trends.  

The report provides an extensive overview of the future trends in lab automation purchasing and which factors will influence those procurement decisions, as well as the technologies labs are most likely to invest in in the future. 

Rising cost pressures, skill shortages, securing funding, hiring freezes, and supply chain issues are all identified as challenges to future drug discovery and development. 

Geographically, the research finds that North America is seen as one region offering significant opportunities in the next twelve months. 

The report is based on detailed survey responses from lab directors/managers, group leaders, project managers, professors and research scientist across the life sciences/biotechnology industry and research universities/institutes, all of whom are influential in equipment purchasing decisions.  

Key questions addressed by this report: 

• What are the market trends and factors that will affect automation spend in the next 12 months?  
• What are the key challenges faced by labs when using lab automation equipment?  
• Which elements impact the choice of lab automation supplier?  
• Which factors will influence future buying trends and create new market opportunities?  
• Where are the barriers preventing lab automation uptake? 

Diana Spencer, Senior Digital Content Editor, DDW